Neurologists explain how primary care, virtual care and specialists can turn concern into a care plan when memory changes appear without a clear diagnosis.

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Commission (EC) has approved KEYTRUDA ® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination ...

All kinds of films, from big-budget spectacles to art house dramas, are stretching their runtimes. It’s an old saying that a ...

A single-patient case report documents recurrent bacterial and fungal urinary tract infections in an infant with neurogenic bladder after congenital dermal sinus surgery and highlights the risks of ...

A critical review finds that clinical signals for Chinese herbal medicines against recurrent urinary tract infection are ...

The 78-year-old NFL legend opens up about his new memoir and why he has no interest in a farewell tribute.

In an eye-opening documentary, she meets long-term ketamine users. Plus: never-before-seen clips from Only Fools and Horses. Here’s what to watch this evening ...

The newly approved regimen offers a chemotherapy-free perioperative approach and is authorised for use across all 27 EU ...

Daring adventurers conquered the wild currents of Calderas River in Antioquia, Colombia, as captured in a video shared by ...

Watch as two friends dive into the ultimate Total Football Quiz, testing their football knowledge by guessing player names ...

Merck’s Keytruda plus Padcev receives European Commission approval to treat adults with resectable muscle-invasive bladder cancer: Rahway, New Jersey Friday, October 23, 2026, 1 ...